APA Citation

Hashemian, S. M., Khoundabi, B., & Velayati, A. A. (2022). Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. Int Immunopharmacol.

Citação norma Chicago

Hashemian, Seyed MohammadReza, Batoul Khoundabi, and Ali Akbar Velayati. "Comment On: Safety and Efficacy of Favipiravir in Moderate to Severe SARS-CoV-2 Pneumonia." Int Immunopharmacol 2022.

MLA Citation

Hashemian, Seyed MohammadReza, Batoul Khoundabi, and Ali Akbar Velayati. "Comment On: Safety and Efficacy of Favipiravir in Moderate to Severe SARS-CoV-2 Pneumonia." Int Immunopharmacol 2022.

Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.